Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
When deciding on the type of treatment, increased life expectancy is the most important consideration for people with MIBC. The risk of long-term complications and changes to overall body image as a result of treatment are also important. Our study also highlighted that patients are willing to accept a higher risk of long-term complications to improve other treatment outcomes. Understanding patient preferences is important for shared decision-making, which has an impact on quality of care for people living with MIBC.
Authors
- Mieke Van Hemelrijck (ORCID: https://orcid.org/0000-0002-7317-0858)
- Deborah Enting (ORCID: https://orcid.org/0000-0001-7508-7540)
- Vinod Mullassery
- Muhammad Shamim Khan (ORCID: https://orcid.org/0000-0002-1861-0830)
- Liam Mannion (ORCID: https://orcid.org/0000-0002-9400-9238)
- Suzanne Amery
- Kathryn Chatterton
- Verity Watson (ORCID: https://orcid.org/0000-0002-3824-5076)
- Simon Hughes (ORCID: https://orcid.org/0000-0002-8332-1584)
- Kate Smith (ORCID: https://orcid.org/0000-0002-1685-2051)
- Rajesh Nair (ORCID: https://orcid.org/0000-0003-1760-9608)
- Margaret Northover
- Ramesh Thurairaja
- Thomas Charlton
Institutions
- Royal Marsden NHS Foundation Trust (GB)
- City, University of London (GB)
- King's College London (GB)
- University of Aberdeen (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
Publication Details
- Journal
- BJUI Compass
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1002/bco2.443
- Citations
- 7
- Primary Topic
- Economic and Environmental Valuation
- Type
- article
- Field-Weighted Citation Impact
- 7.90